Iveric Bio Receives Permanent J-code for GA Treatment Izervay – Eyewire+
Iveric Bio, a subsidiary of Astellas, announced that CMS has assigned a unique, permanent Healthcare Common Procedure Coding System (HC
Iveric Bio, a subsidiary of Astellas, announced that CMS has assigned a unique, permanent Healthcare Common Procedure Coding System (HC
The company expects to launch the supplement in the US, which features a proprietary blend of ingredients including lutein, zeaxanthin isomers, curcumin and vitamin D3,…
This randomized clinical trial evaluates the efficacy and safety of daily 650-nm low-level red light for myopia treatment among children aged 6 to 12 years…
At the 2024 ASCRS meeting, David M. Lubeck detailed highlights from his presentations on the minimally invasive glaucoma surgery (MIGS) space.
Results show a 0.94 correlation in mean deviation and statistical noninferiority to traditional methods for staging glaucoma.
This randomized clinical trial investigates the safety and effectiveness of a water-free cyclosporine ophthalmic solution, 0.1%, for dry eye disease.
This case report describes a diagnosis of morning glory syndrome in a 2-week-old infant who presented with divergent strabismus, cleft lip, and hypertelorism.
The company announced results from a Phase IV study of tropicamide and phenylephrine hydrochloride ophthalmic spray 1%/2.5% (Mydcombi) designed to characterize the efficacy and duration…
Cataract simulation platform uses virtual reality to train ophthalmologists